Journal of Reproductive Immunology
Volume 82, Issue 2 , Pages 100-105 , November 2009

The link between insulin resistance and preeclampsia: new perspectives

  • Marco Scioscia

      Affiliations

    • Department of Obstetrics and Gynaecology, Sacro Cuore Don Calabria, Negrar, Verona, Italy
    • Department of Perinatal Medicine, Tor Vergata University, Rome, Italy
    • Corresponding Author InformationCorresponding author at: Department of Obstetrics and Gynaecology, Sacro Cuore Don Calabria General Hospital, Via Don A. Sempreboni, 5, 37024 Negrar, VR, Italy. Tel.: +39 0349 872 4206; fax: +39 045 750 0480.
    • ,
  • Khalid Gumaa

      Affiliations

    • College of Medicine and Medical Sciences, Arabian Gulf University, Manama, Bahrain
    • ,
  • Thomas W. Rademacher

      Affiliations

    • Department of Immunology and Molecular Pathology, Molecular Medicine Unit, Royal Free and University College London Medical School, London, United Kingdom

Received 14 January 2009 ,Revised 6 April 2009 ,Accepted 20 April 2009.

References 

  1. Bartha JL, Gonzalez-Bugatto F, Fernandez-Macias R, Gonzalez-Gonzalez NL, Comino-Delgado R, Hervias-Vivancos B. Metabolic syndrome in normal and complicated pregnancies. Eur. J. Obstet. Gynecol. Reprod. Biol. 2008;137:178–184
  2. Bryson CL, Ioannou GN, Rulyak SJ, Critchlow C. Association between gestational diabetes and pregnancy-induced hypertension. Am. J. Epidemiol. 2003;158:1148–1153
  3. Caro HN, Sheikh NA, Taverne J, Playfair JH, Rademacher TW. Structural similarities among malaria toxins insulin second messengers, and bacterial endotoxin. Infect. Immun. 1996;64:3438–3441
  4. Chaouat G. Current knowledge on natural killer cells, pregnancy and pre-eclampsia. Introduction. Reprod. Biomed. Online. 2008;16:170–172
  5. Deborde S, Schofield JN, Rademacher TW. Placental GPI-PLD is of maternal origin and its GPI substrate is absent from placentae of pregnancies associated with pre-eclampsia. J. Reprod. Immunol. 2003;59:277–294
  6. Dekker G, Robillard PY. Pre-eclampsia: is the immune maladaptation hypothesis still standing? An epidemiological update. J Reprod. Immunol. 2007;76:8–16
  7. Elased KM, Gumaa KA, de Souza JB, Playfair JH, Rademacher TW. Improvement of glucose homeostasis in obese diabetic db/db mice given Plasmodium yoelii glycosylphosphatidylinositols. Metabolism. 2004;53:1048–1053
  8. Elased KM, Gumaa KA, de Souza JB, Rahmoune H, Playfair JH, Rademacher TW. Reversal of type 2 diabetes in mice by products of malaria parasites. II. Role of inositol phosphoglycans (IPGs). Mol. Genet. Metab. 2001;73:248–258
  9. Emery SP, Levine RJ, Qian C, Ewell MG, England LJ, Yu KF, et al. Twenty-four-hour urine insulin as a measure of hyperinsulinaemia/insulin resistance before onset of pre-eclampsia and gestational hypertension. BJOG. 2005;112:1479–1485
  10. Frick W, Bauer A, Bauer J, Wied S, Muller G. Structure–activity relationship of synthetic phosphoinositolglycans mimicking metabolic insulin action. Biochemistry. 1998;37:13421–13436
  11. Getahun D, Ananth CV, Oyelese Y, Chavez MR, Kirby RS, Smulian JC. Primary preeclampsia in the second pregnancy: effects of changes in prepregnancy body mass index between pregnancies. Obstet. Gynecol. 2007;110:1319–1325
  12. Gual P, Marchand-Brustel Y, Tanti JF. Positive and negative regulation of insulin signaling through IRS-1 phosphorylation. Biochimie. 2005;87:99–109
  13. Kennington AS, Hill CR, Craig J, Bogardus C, Raz I, Ortmeyer HK, et al. Low urinary chiro-inositol excretion in non-insulin-dependent diabetes mellitus. N. Engl. J. Med. 1990;323:373–378
  14. Kunjara S, Greenbaum AL, Wang DY, Caro HN, McLean P, Redman CW, et al. Inositol phosphoglycans and signal transduction systems in pregnancy in preeclampsia and diabetes: evidence for a significant regulatory role in preeclampsia at placental and systemic levels. Mol. Genet. Metab. 2000;69:144–158
  15. Kunjara S, McLean P, Greenbaum AL, Rademacher TW. Insight into the role of inositol phosphoglycans in insulin response and the regulation of glucose and lipid metabolism illustrated by the response of adipocytes from two strains of rats. Mol. Genet. Metab. 2008;94:263–266
  16. Kunjara S, Wang DY, Greenbaum AL, McLean P, Kurtz A, Rademacher TW. Inositol phosphoglycans in diabetes and obesity: urinary levels of IPG A-type and IPG P-type, and relationship to pathophysiological changes. Mol. Genet. Metab. 1999;68:488–502
  17. Kunjara S, Wang DY, McLean P, Greenbaum AL, Rademacher TW. Inositol phosphoglycans and the regulation of the secretion of leptin: in vitro effects on leptin release from adipocytes and the relationship to obesity. Mol. Genet. Metab. 2000;70:61–68
  18. Larner J. d-Chiro-inositol—its functional role in insulin action and its deficit in insulin resistance. Int. J. Exp. Diabetes Res. 2002;3:47–60
  19. Levine RJ, Maynard SE, Qian C, Lim KH, England LJ, Yu KF, et al. Circulating angiogenic factors and the risk of preeclampsia. N. Engl. J. Med. 2004;350:672–683
  20. Mackay AP, Berg CJ, Atrash HK. Pregnancy-related mortality from preeclampsia and eclampsia. Obstet. Gynecol. 2001;97:533–538
  21. Misek DE, Saltiel AR. An inositol phosphate glycan derived from a Trypanosoma brucei glycosyl phosphatidylinositol promotes protein dephosphorylation in rat epididymal adipocytes. Endocrinology. 1994;135:1869–1876
  22. Montoro MN, Kjos SL, Chandler M, Peters RK, Xiang AH, Buchanan TA. Insulin resistance and preeclampsia in gestational diabetes mellitus. Diabetes Care. 2005;28:1995–2000
  23. Ostlund I, Haglund B, Hanson U. Gestational diabetes and preeclampsia. Eur. J Obstet. Gynecol. Reprod. Biol. 2004;113:12–16
  24. Paine MA, Scioscia M, Gumaa KA, Rodeck CH, Rademacher TW. P-type inositol phosphoglycans in serum and amniotic fluid in active pre-eclampsia. J. Reprod. Immunol. 2006;69:165–179
  25. Rademacher TW, Caro H, Kunjara S, Wang DY, Greenbaum AL, McLean P. Inositolphosphoglycan second messengers. Braz. J. Med. Biol. Res. 1994;27:327–341
  26. Rademacher TW, Gumaa K, Scioscia M. Preeclampsia, insulin signalling and immunological dysfunction: a fetal, maternal or placental disorder?. J. Reprod. Immunol. 2007;76:78–84
  27. Redman CW, Sargent IL. Pre-eclampsia, the placenta and the maternal systemic inflammatory response—a review. Placenta. 2003;24(Suppl. A):S21–S27
  28. Redman CW, Sargent IL. Latest advances in understanding preeclampsia. Science. 2005;308:1592–1594
  29. Robillard PY, Dekker G, Chaouat G, Hulsey TC. Etiology of preeclampsia: maternal vascular predisposition and couple disease—mutual exclusion or complementarity?. J. Reprod. Immunol. 2007;76:1–7
  30. Robillard PY, Hulsey TC. Association of pregnancy-induced-hypertension, pre-eclampsia, and eclampsia with duration of sexual cohabitation before conception. Lancet. 1996;347:619
  31. Saito S, Sakai M. Th1/Th2 balance in preeclampsia. J. Reprod. Immunol. 2003;59:161–173
  32. Scioscia M, Greco P, Selvaggi LE, Rademacher TW. Is there a link between insulin resistance and inflammatory activation in preeclampsia?. Med. Hypoth. 2009;
  33. Scioscia M, Gumaa K, Kunjara S, Paine MA, Selvaggi LE, Rodeck CH, et al. Insulin resistance in human preeclamptic placenta is mediated by serine phosphorylation of insulin receptor substrate-1 and -2. J. Clin. Endocrinol. Metab. 2006;91:709–717
  34. Scioscia, M., Gumaa, K., Selvaggi, L.E., Rodeck, C.H., Rademacher, T.W., in press. Increased inositol phosphoglycan P-type in the second trimester in pregnant women with type 2 and gestational diabetes mellitus. J. Perinat. Med.
  35. Scioscia M, Gumaa K, Whitten M, Selvaggi LE, Rodeck CH, Rademacher TW. Inositol phosphoglycan P-type in healthy and preeclamptic pregnancies. J. Reprod. Immunol. 2007;76:85–90
  36. Scioscia M, Kunjara S, Gumaa K, Gomez Galan AM, McLean P, Rodeck CH, et al. Altered urinary release of inositol phosphoglycan A-type in women with gestational diabetes mellitus. Gynecol. Obstet. Invest. 2007;64:217–223
  37. Scioscia M, Kunjara S, Gumaa K, McLean P, Rodeck CH, Rademacher TW. Urinary excretion of inositol phosphoglycan P-type in gestational diabetes mellitus. Diabet. Med. 2007;24:1300–1304
  38. Scioscia M, Paine MA, Gumaa K, Rodeck CH, Rademacher TW. Release of inositol phosphoglycan P-type by the human placenta following insulin stimulus: a multiple comparison between preeclampsia, intrauterine growth restriction, and gestational hypertension. J. Matern. Fetal Neonatal Med. 2008;21:581–585
  39. Seely EW, Solomon CG. Insulin resistance and its potential role in pregnancy-induced hypertension. J. Clin. Endocrinol. Metab. 2003;88:2393–2398
  40. Shashkin PN, Shashkina EF, Fernqvist-Forbes E, Zhou YP, Grill V, Katz A. Insulin mediators in man: effects of glucose ingestion and insulin resistance. Diabetologia. 1997;40:557–563
  41. Sibai B, Dekker G, Kupferminc M. Pre-eclampsia. Lancet. 2005;365:785–799
  42. Sowers JR, Saleh AA, Sokol RJ. Hyperinsulinemia and insulin resistance are associated with preeclampsia in African-Americans. Am. J. Hypertens. 1995;8:1–4
  43. Suzuki S, Kawasaki H, Satoh Y, Ohtomo M, Hirai M, Hirai A, et al. Urinary chiro-inositol excretion is an index marker of insulin sensitivity in Japanese type II diabetes. Diabetes Care. 1994;17:1465–1468
  44. Varela-Nieto I, Leon Y, Caro HN. Cell signalling by inositol phosphoglycans from different species. Comp. Biochem. Physiol. B: Biochem. Mol. Biol. 1996;115:223–241
  45. Vatten LJ, Skjaerven R. Is pre-eclampsia more than one disease?. BJOG. 2004;111:298–302
  46. Virkamaki A, Ueki K, Kahn CR. Protein–protein interaction in insulin signaling and the molecular mechanisms of insulin resistance. J. Clin. Invest. 1999;103:931–943
  47. Williams PJ, Gumaa K, Scioscia M, Redman CW, Rademacher TW. Inositol phosphoglycan P-type in preeclampsia: a novel marker?. Hypertension. 2007;49:84–89
  48. Xiong X, Demianczuk NN, Saunders LD, Wang FL, Fraser WD. Impact of preeclampsia and gestational hypertension on birth weight by gestational age. Am. J. Epidemiol. 2002;155:203–209

PII: S0165-0378(09)00252-6

doi: 10.1016/j.jri.2009.04.009

Journal of Reproductive Immunology
Volume 82, Issue 2 , Pages 100-105 , November 2009

Article Tools

* Image Usage & Resolution